Glen Harbor Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | $597K | Buy |
13,384
+5,348
| +67% | +$239K | 0.01% | 644 |
|
2019
Q2 | $332K | Buy |
8,036
+1,260
| +19% | +$52.1K | 0.01% | 849 |
|
2019
Q1 | $274K | Buy |
6,776
+1,428
| +27% | +$57.7K | 0.01% | 894 |
|
2018
Q4 | $203K | Sell |
5,348
-10,584
| -66% | -$402K | ﹤0.01% | 940 |
|
2018
Q3 | $630K | Hold |
15,932
| – | – | 0.01% | 622 |
|
2018
Q2 | $559K | Buy |
15,932
+896
| +6% | +$31.4K | 0.01% | 606 |
|
2018
Q1 | $526K | Hold |
15,036
| – | – | 0.01% | 619 |
|
2017
Q4 | $522K | Hold |
15,036
| – | – | 0.01% | 629 |
|
2017
Q3 | $509K | Hold |
15,036
| – | – | 0.01% | 592 |
|
2017
Q2 | $512K | Hold |
15,036
| – | – | 0.01% | 590 |
|
2017
Q1 | $468K | Hold |
15,036
| – | – | 0.01% | 573 |
|
2016
Q4 | $411K | Buy |
+15,036
| New | +$411K | 0.01% | 549 |
|